ExCell Bio Overview
- Year Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Debt
- Latest Deal Amount
-
$881K
- Investors
-
12
ExCell Bio General Information
Description
Supplier of biological reagents and consumables for the upstream tool industry of biomedicine. The company provides raw materials and technical services for customers in the fields of biopharmaceuticals, precision medicine and so on, its products include serum-free culture medium, foetal bovine serum and functional identification kits, committing to accelerating the application of life science and technology and continuously improving human health.
Contact Information
Website
www.excellbio.comCorporate Office
- 5th Floor, Building 18
- No. 481, Guiping Road, Xuhui District
- Shanghai, 200233
- China
Corporate Office
- 5th Floor, Building 18
- No. 481, Guiping Road, Xuhui District
- Shanghai, 200233
- China
ExCell Bio Timeline
ExCell Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Debt - General | 27-Jun-2023 | $881K | Completed | |||
| 6. Later Stage VC (Series B2) | 09-May-2023 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B1) | 07-Jan-2023 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 22-Oct-2021 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 12-Oct-2020 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 01-Aug-2020 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 02-Dec-2016 | Completed | Generating Revenue |
ExCell Bio Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ABCI Securities | Investment Bank | Minority | ||
| GP Capital (Shanghai) | PE/Buyout | Minority | ||
| Shenzhen Investment Holdings | Asset Manager | Minority | ||
| Haiwang Capital | Venture Capital | Minority | ||
| CICC Private Equity | Corporate Venture Capital | Minority |
ExCell Bio FAQs
-
When was ExCell Bio founded?
ExCell Bio was founded in 2013.
-
Where is ExCell Bio headquartered?
ExCell Bio is headquartered in Shanghai, China.
-
What industry is ExCell Bio in?
ExCell Bio’s primary industry is Biotechnology.
-
Is ExCell Bio a private or public company?
ExCell Bio is a Private company.
-
What is ExCell Bio’s current revenue?
The current revenue for ExCell Bio is .
-
How much funding has ExCell Bio raised over time?
ExCell Bio has raised $60M.
-
Who are ExCell Bio’s investors?
ABCI Securities, GP Capital (Shanghai), Shenzhen Investment Holdings, Haiwang Capital, and CICC Private Equity are 5 of 12 investors who have invested in ExCell Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process